{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:08:19Z","timestamp":1749614899394,"version":"3.41.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ccm.2024.10.011","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:26:44Z","timestamp":1734524804000},"page":"149-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary Immunocompromise in Solid Organ Transplantation"],"prefix":"10.1016","volume":"46","author":[{"given":"Elizabeth A.","family":"Lendermon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadi A.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ccm.2024.10.011_bib2","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.ccm.2024.10.011_bib3","doi-asserted-by":"crossref","first-page":"e13545","DOI":"10.1111\/ctr.13545","article-title":"Pneumonia in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Dulek","year":"2019","journal-title":"Clin Transplant"},{"issue":"8","key":"10.1016\/j.ccm.2024.10.011_bib4","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1600-6143.2007.01882.x","article-title":"Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study","volume":"7","author":"Aguilar-Guisado","year":"2007","journal-title":"Am J Transplant"},{"issue":"17","key":"10.1016\/j.ccm.2024.10.011_bib5","first-page":"5532","article-title":"Association between hospital-acquired pneumonia and in-hospital mortality in solid organ transplant admissions: an observational analysis in Spain, 2004-2021","volume":"12","author":"de-Miguel-Yanes","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"7","key":"10.1016\/j.ccm.2024.10.011_bib6","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \"net state of immunosuppression\"","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2024.10.011_bib7","doi-asserted-by":"crossref","first-page":"605945","DOI":"10.3389\/fimmu.2021.605945","article-title":"Interstitial lung disease in common variable immunodeficiency","volume":"12","author":"Lopes","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2024.10.011_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/00365540600978955","article-title":"Common variable immune deficiency and lung transplantation","volume":"39","author":"Burton","year":"2007","journal-title":"Scand J Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2024.10.011_bib9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thx.53.7.622","article-title":"Heart lung transplantation in a patient with end stage lung disease due to common variable immunodeficiency","volume":"53","author":"Hill","year":"1998","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ccm.2024.10.011_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10875-019-00623-6","article-title":"Successful lung transplantation in a patient with chronic granulomatous disease","volume":"39","author":"Xie","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2024.10.011_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"5271","key":"10.1016\/j.ccm.2024.10.011_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus","volume":"273","author":"Miller","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0889-857X(05)70151-4","article-title":"Changes in immune function with age","volume":"26","author":"Yung","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.ccm.2024.10.011_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ni1033","article-title":"Age-related changes in lymphocyte development and function","volume":"5","author":"Linton","year":"2004","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2024.10.011_bib15","doi-asserted-by":"crossref","first-page":"e4097","DOI":"10.1371\/journal.pone.0004097","article-title":"Aging impairs recipient T cell intrinsic and extrinsic factors in response to transplantation","volume":"4","author":"Shen","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ccm.2024.10.011_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.TP.0000146258.79425.04","article-title":"Age and immune response in organ transplantation","volume":"79","author":"Martins","year":"2005","journal-title":"Transplantation"},{"issue":"2\u20133","key":"10.1016\/j.ccm.2024.10.011_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0966-3274(02)00058-8","article-title":"Rejection and recipient age","volume":"10","author":"Bradley","year":"2002","journal-title":"Transpl Immunol"},{"issue":"11","key":"10.1016\/j.ccm.2024.10.011_bib18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"Gavazzi","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2024.10.011_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/00007890-200003150-00037","article-title":"Increased immunosuppressive vulnerability in elderly renal transplant recipients","volume":"69","author":"Meier-Kriesche","year":"2000","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.ccm.2024.10.011_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1172\/JCI66370","article-title":"Telomeres and age-related disease: how telomere biology informs clinical paradigms","volume":"123","author":"Armanios","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ccm.2024.10.011_bib22","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.healun.2023.08.001","article-title":"Impact of age and telomere length on circulating T cells and rejection risk after lung transplantation for idiopathic pulmonary fibrosis","volume":"42","author":"Snyder","year":"2023","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1164\/rccm.201805-0825OC","article-title":"Impaired cytomegalovirus immunity in idiopathic pulmonary fibrosis lung transplant recipients with short telomeres","volume":"199","author":"Popescu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2024.10.011_bib24","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ajt.2023.06.014","article-title":"Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications","volume":"23","author":"Hannan","year":"2023","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2024.10.011_bib25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1600-6143.2009.02887.x","article-title":"Introduction: infection in solid organ transplant recipients","volume":"9","author":"Fishman","year":"2009","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2024.10.011_bib26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transplant"},{"issue":"25","key":"10.1016\/j.ccm.2024.10.011_bib27","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccm.2024.10.011_bib28","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/infdis\/jiz039","article-title":"Torque teno virus for risk stratification of acute biopsy-proven alloreactivity in kidney transplant recipients","volume":"219","author":"Strassl","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2024.10.011_bib29","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiy306","article-title":"Quantification of Torque teno virus viremia as a prospective biomarker for infectious disease in kidney allograft recipients","volume":"218","author":"Strassl","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-0012.2009.00976.x","article-title":"CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study","volume":"24","author":"Sund","year":"2010","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/cid\/civ871","article-title":"Symptomatic respiratory virus infection and chronic lung allograft dysfunction","volume":"62","author":"Fisher","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2024.10.011_bib32","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.healun.2022.06.011","article-title":"The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: a multicenter experience","volume":"41","author":"Roosma","year":"2022","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.ccm.2024.10.011_bib33","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1111\/ajt.16073","article-title":"Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients","volume":"20","author":"de Zwart","year":"2020","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/cid\/civ877","article-title":"Editorial commentary: chronic lung allograft dysfunction in lung transplant recipients: another piece of the puzzle","volume":"62","author":"Gardiner","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ccm.2024.10.011_bib35","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1600-6143.2009.02699.x","article-title":"Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study","volume":"9","author":"Zafrani","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ccm.2024.10.011_bib36","first-page":"502","article-title":"Infections associated with neutropenia and transplantation","volume":"21","author":"Wey","year":"2010","journal-title":"Antibiotic and Chemotherapy"},{"issue":"9","key":"10.1016\/j.ccm.2024.10.011_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/cid\/ciy295","article-title":"Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients","volume":"67","author":"Gardiner","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2024.10.011_bib38","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181b4ee9a","article-title":"Obesity, surgical site infection, and outcome following renal transplantation","volume":"250","author":"Lynch","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ccm.2024.10.011_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1478-3231.2009.02135.x","article-title":"Nutritional status: its influence on the outcome of patients undergoing liver transplantation","volume":"30","author":"Merli","year":"2010","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.ccm.2024.10.011_bib40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.tp.0000234905.56926.7f","article-title":"Induction immunosuppression","volume":"82","author":"Kirk","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib41","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.transproceed.2020.01.054","article-title":"Low-dose thymoglobulin vs basiliximab induction therapy in low-risk living related kidney transplant recipients: a prospective randomized trial","volume":"53","author":"Martinez-Mier","year":"2021","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib42","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10157-017-1480-z","article-title":"Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2018","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"10.1016\/j.ccm.2024.10.011_bib43","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.transproceed.2008.07.113","article-title":"Induction immunosuppression with basiliximab in heart transplantation","volume":"40","author":"Chou","year":"2008","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.ccm.2024.10.011_bib44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.transproceed.2010.02.088","article-title":"Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis","volume":"42","author":"Liu","year":"2010","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.ccm.2024.10.011_bib45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2362.2011.02490.x","article-title":"Long-term outcome of ATG vs. Basiliximab induction","volume":"41","author":"Ulrich","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib46","doi-asserted-by":"crossref","first-page":"e13257","DOI":"10.1111\/tid.13257","article-title":"Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab","volume":"22","author":"Pham","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2024.10.011_bib47","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.TP.0000129812.68794.CC","article-title":"Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids","volume":"78","author":"Mourad","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ccm.2024.10.011_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy","volume":"2","author":"Lebranchu","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ccm.2024.10.011_bib49","doi-asserted-by":"crossref","first-page":"11834","DOI":"10.3389\/ti.2023.11834","article-title":"A\u00a0decade of experience with alemtuzumab therapy for severe or glucocorticoid-resistant kidney transplant rejection","volume":"36","author":"van Vugt","year":"2023","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.ccm.2024.10.011_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1086\/510388","article-title":"Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.ccm.2024.10.011_bib51","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccm.2024.10.011_bib52","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.healun.2010.04.022","article-title":"Cytomegalovirus disease among donor-positive\/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis","volume":"29","author":"Mitsani","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ccm.2024.10.011_bib53","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/ajt.15756","article-title":"Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival","volume":"20","author":"Iasella","year":"2020","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2024.10.011_bib54","first-page":"241","article-title":"Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion","volume":"53","author":"Silveira","year":"2006","journal-title":"J\u00a0Infect"},{"issue":"2","key":"10.1016\/j.ccm.2024.10.011_bib55","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.transproceed.2004.12.019","article-title":"Reversal of acute cellular rejection after renal transplantation with Campath-1H","volume":"37","author":"Basu","year":"2005","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.ccm.2024.10.011_bib56","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1111\/j.1600-6143.2007.02000.x","article-title":"Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation","volume":"7","author":"Reams","year":"2007","journal-title":"Am J Transplant"},{"issue":"25","key":"10.1016\/j.ccm.2024.10.011_bib57","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2024.10.011_bib58","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5414\/CN111137","article-title":"Elevated tacrolimus levels among COVID-19 kidney transplant recipients are associated with worse disease severity and clinical outcomes","volume":"100","author":"Yango","year":"2023","journal-title":"Clin Nephrol"},{"issue":"7","key":"10.1016\/j.ccm.2024.10.011_bib59","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2018010009","article-title":"Everolimus with reduced calcineurin inhibitor exposure in renal transplantation","volume":"29","author":"Pascual","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A\u00a0phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib61","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A\u00a0phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ccm.2024.10.011_bib62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2024.10.011_bib63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16132","article-title":"CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept","volume":"21","author":"Karadkhele","year":"2021","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ccm.2024.10.011_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/TP.0000000000001873","article-title":"Maintenance belatacept-based immunosuppression in lung transplantation recipients who failed calcineurin inhibitors","volume":"102","author":"Iasella","year":"2018","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.ccm.2024.10.011_bib65","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/ajt.17028","article-title":"A\u00a0pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation","volume":"22","author":"Huang","year":"2022","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ccm.2024.10.011_bib66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.transproceed.2016.01.003","article-title":"Invasive tracheobronchial aspergillosis in a lung transplant recipient receiving belatacept as salvage maintenance immunosuppression: a case report","volume":"48","author":"Haidar","year":"2016","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.ccm.2024.10.011_bib67","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/tri.12321","article-title":"Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation","volume":"27","author":"Fernandez-Ruiz","year":"2014","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.ccm.2024.10.011_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/TP.0b013e318239e90c","article-title":"Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients","volume":"93","author":"Calarota","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ccm.2024.10.011_bib69","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcv.2015.06.078","article-title":"T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation","volume":"69","author":"Calarota","year":"2015","journal-title":"J\u00a0Clin Virol"},{"issue":"12","key":"10.1016\/j.ccm.2024.10.011_bib70","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/01.TP.0000159136.72693.35","article-title":"Risk factors and outcomes of hypogammaglobulinemia after lung transplantation","volume":"79","author":"Kawut","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.ccm.2024.10.011_bib71","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/tid.12593","article-title":"Hypogammaglobulinemia and risk of severe infection in kidney transplant recipients","volume":"18","author":"Augusto","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.ccm.2024.10.011_bib72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trim.2009.12.004","article-title":"Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients","volume":"22","author":"Wang","year":"2010","journal-title":"Transpl Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2024.10.011_bib73","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1399-0012.2007.00732.x","article-title":"Pre-transplant level of soluble CD30 is associated with infection after heart transplantation","volume":"21","author":"Nikaein","year":"2007","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.ccm.2024.10.011_bib74","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TP.0b013e31826784ad","article-title":"Pretransplantation soluble CD30 level as a predictor of acute rejection in kidney transplantation: a meta-analysis","volume":"94","author":"Chen","year":"2012","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ccm.2024.10.011_bib75","first-page":"467","article-title":"Invasive fungal infection after liver transplantation: risk factors and significance of immune cell function monitoring","volume":"12","author":"Zhou","year":"2011","journal-title":"J\u00a0Dig Dis"},{"issue":"7","key":"10.1016\/j.ccm.2024.10.011_bib76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/TP.0b013e3182466248","article-title":"Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis","volume":"93","author":"Ling","year":"2012","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ccm.2024.10.011_bib77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/tid.12534","article-title":"Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections","volume":"18","author":"Crepin","year":"2016","journal-title":"Transpl Infect Dis"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523124001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523124001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:09:28Z","timestamp":1749553768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523124001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0272523124001023"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2024.10.011","relation":{},"ISSN":["0272-5231"],"issn-type":[{"type":"print","value":"0272-5231"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Immunocompromise in Solid Organ Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2024.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}